A Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis

20031,242 citationsJournal Articlebronze Open Access

Authors

David H. Miller · MRC Prion Unit

Omar Khan · Wayne State University

William Sheremata · University of Miami

Abstract

In a placebo-controlled trial, treatment with natalizumab led to fewer inflammatory brain lesions and fewer relapses over a six-month period in patients with relapsing multiple sclerosis.

Topics & Keywords

Multiple Sclerosis Research Studies Immunotherapy and Immune Responses Peripheral Neuropathies and Disorders

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 348, Issue 1, pp. 15-23

DOI: 10.1056/nejmoa020696

Field-Weighted Citation Impact: 72.14